Literature DB >> 20974904

The combined analysis of uncertainty and patient heterogeneity in medical decision models.

Bas Groot Koerkamp1,2, Theo Stijnen3, Milton C Weinstein4, M G Myriam Hunink1,4.   

Abstract

The analysis of both patient heterogeneity and parameter uncertainty in decision models is increasingly recommended. In addition, the complexity of current medical decision models commonly requires simulating individual subjects, which introduces stochastic uncertainty. The combined analysis of uncertainty and heterogeneity often involves complex nested Monte Carlo simulations to obtain the model outcomes of interest. In this article, the authors distinguish eight model types, each dealing with a different combination of patient heterogeneity, parameter uncertainty, and stochastic uncertainty. The analyses that are required to obtain the model outcomes are expressed in equations, explained in stepwise algorithms, and demonstrated in examples. Patient heterogeneity is represented by frequency distributions and analyzed with Monte Carlo simulation. Parameter uncertainty is represented by probability distributions and analyzed with 2nd-order Monte Carlo simulation (aka probabilistic sensitivity analysis). Stochastic uncertainty is analyzed with 1st-order Monte Carlo simulation (i.e., trials or random walks). This article can be used as a reference for analyzing complex models with more than one type of uncertainty and patient heterogeneity.

Entities:  

Mesh:

Year:  2010        PMID: 20974904     DOI: 10.1177/0272989X10381282

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  15 in total

1.  Characterizing Heterogeneity Bias in Cohort-Based Models.

Authors:  Elamin H Elbasha; Jagpreet Chhatwal
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

2.  Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity.

Authors:  Mathilda L Bongers; Dirk de Ruysscher; Cary Oberije; Philippe Lambin; Carin A Uyl-de Groot; V M H Coupé
Journal:  Med Decis Making       Date:  2015-03-02       Impact factor: 2.583

3.  A novel mathematical approach to diagnose premenstrual syndrome.

Authors:  Subhagata Chattopadhyay; U Rajendra Acharya
Journal:  J Med Syst       Date:  2011-04-05       Impact factor: 4.460

4.  Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.

Authors:  Yue Huang; Chris Kypridemos; Junxiu Liu; Yujin Lee; Jonathan Pearson-Stuttard; Brendan Collins; Piotr Bandosz; Simon Capewell; Laurie Whitsel; Parke Wilde; Dariush Mozaffarian; Martin O'Flaherty; Renata Micha
Journal:  Circulation       Date:  2019-04-15       Impact factor: 29.690

5.  A Framework for Prioritizing Research Investments in Precision Medicine.

Authors:  Anirban Basu; Josh J Carlson; David L Veenstra
Journal:  Med Decis Making       Date:  2015-10-26       Impact factor: 2.583

6.  Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.

Authors:  Martin O'Flaherty; Ffion Lloyd-Williams; Simon Capewell; Angela Boland; Michelle Maden; Brendan Collins; Piotr Bandosz; Lirije Hyseni; Chris Kypridemos
Journal:  Health Technol Assess       Date:  2021-05       Impact factor: 4.014

7.  Cost-effectiveness of caries excavations in different risk groups - a micro-simulation study.

Authors:  Falk Schwendicke; Sebastian Paris; Michael Stolpe
Journal:  BMC Oral Health       Date:  2014-12-15       Impact factor: 2.757

8.  Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions.

Authors:  Adam D M Briggs; Jane Wolstenholme; Tony Blakely; Peter Scarborough
Journal:  Popul Health Metr       Date:  2016-05-04

9.  Validation of a model to investigate the effects of modifying cardiovascular disease (CVD) risk factors on the burden of CVD: the rotterdam ischemic heart disease and stroke computer simulation (RISC) model.

Authors:  Bob J H van Kempen; Bart S Ferket; Albert Hofman; Ewout W Steyerberg; Ersen B Colkesen; S Matthijs Boekholdt; Nicholas J Wareham; Kay-Tee Khaw; M G Myriam Hunink
Journal:  BMC Med       Date:  2012-12-06       Impact factor: 8.775

10.  Cancer care coordinators in stage III colon cancer: a cost-utility analysis.

Authors:  Tony Blakely; Lucie Collinson; Giorgi Kvizhinadze; Nisha Nair; Rachel Foster; Elizabeth Dennett; Diana Sarfati
Journal:  BMC Health Serv Res       Date:  2015-08-05       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.